image_pdfimage_print
26 07, 2023

SB 805 (see companion bill HB 1217)

Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations to provide coverage for biomarker testing that is supported by medical and scientific evidence; establishing requirements for deductibles, copayments, and coinsurance for biomarker testing; and requiring the Maryland Health Care Commission to report to certain committees of the General Assembly on the impact of providing biomarker testing.

SB 805 (see companion bill HB 1217)
26 07, 2023

SB 64

Authorizing pharmacists to prescribe and dispense postexposure prophylaxis for HIV prevention to patients under certain circumstances; prohibiting managed care organizations, insurers, nonprofit health service plans, and health maintenance organizations from requiring prior authorization for preexposure prophylaxis for HIV prevention or step therapy or cost-sharing for preexposure prophylaxis for HIV prevention or postexposure prophylaxis for HIV prevention; etc.

SB 64
26 07, 2023

SB 184 (see companion bill HB 376)

Prohibiting, except under certain circumstances, insurers, nonprofit health service plans, and health maintenance organizations that provide coverage for diagnostic and supplemental breast examinations from imposing a copayment, coinsurance, or deductible requirement for the examination; and requiring the Maryland Health Care Commission to study and report to the Governor and certain committees of the General Assembly by October 1, 2023, on the financial impact of eliminating cost-sharing for diagnostic image-guided biopsies for breast cancer.

SB 184 (see companion bill HB 376)
26 07, 2023

HB 376 (see companion bill SB 184)

Prohibiting, except under certain circumstances, insurers, nonprofit health service plans, and health maintenance organizations that provide coverage for diagnostic and supplemental breast examinations from imposing a copayment, coinsurance, or deductible requirement for the examination; and requiring the Maryland Health Care Commission to study and report to the Governor and certain committees of the General Assembly by October 1, 2023, on the financial impact of eliminating cost-sharing for diagnostic image-guided biopsies for breast cancer.

HB 376 (see companion bill SB 184)
26 07, 2023

HB 1108

Altering the process by which health insurance carriers and managed care organizations determine participation by providers on provider panels; and requiring internal review systems to include grievances involving the rejection of a provider's application to participate on a provider panel.

HB 1108
26 07, 2023

HB 1145 (see companion bill SB 397)

Requiring insurers, nonprofit health service plans, and health maintenance organizations that provide certain health insurance benefits under certain insurance policies or contracts to provide certain coverage for certain hearing aids for adults; authorizing a limit on the benefit payable of $1,400 per hearing aid every 36 months; and authorizing an insured or enrollee to choose a certain hearing aid and pay a certain amount for the hearing aid without financial or contractual penalty to the provider of the hearing aid.

HB 1145 (see companion bill SB 397)
26 07, 2023

SB 397 (see companion bill HB 1145)

Requiring insurers, nonprofit health service plans, and health maintenance organizations that provide certain health insurance benefits under certain insurance policies or contracts to provide certain coverage for certain hearing aids for adults; authorizing a limit on the benefit payable of $1,400 per hearing aid every 36 months; and authorizing an insured or enrollee to choose a certain hearing aid and pay a certain amount for the hearing aid without financial or contractual penalty to the provider of the hearing aid.

SB 397 (see companion bill HB 1145)
26 07, 2023

HB 333 (see companion bill SB 404)

Establishing requirements related to the reimbursement of out-of-pocket costs paid by certain hospital patients who were eligible for free care, including requirements related to the consideration of data and the reporting and disclosure of certain information; authorizing the Commission to impose a fine of up to $50,000 per violation if a hospital fails to provide refunds to qualifying patients; making a violation of the Act an unfair, abusive, or deceptive trade practice subject to penalties under the Maryland Consumer Protection Act; etc.

HB 333 (see companion bill SB 404)
26 07, 2023

SB 404 (see companion bill HB 333)

Establishing requirements related to the reimbursement of out-of-pocket costs paid by certain hospital patients who were eligible for free care, including requirements related to the consideration of data and the reporting and disclosure of certain information; authorizing the Commission to impose a fine of up to $50,000 per violation if a hospital fails to provide refunds to qualifying patients; making a violation of the Act an unfair, abusive, or deceptive trade practice subject to penalties under the Maryland Consumer Protection Act; etc.

SB 404 (see companion bill HB 333)
26 07, 2023

SB 101 (see companion bill HB 48)

Repealing the Collaborative Care Pilot Program; and requiring the Maryland Department of Health to expand access to and provide reimbursement for services provided in accordance with the Collaborative Care Model under the Maryland Medical Assistance Program.

SB 101 (see companion bill HB 48)